Gobbi PG - Search Results

1

Lymphomatous superficial lymph nodes: limitations of physical examination for accurate staging and response assessment.

Gobbi PG, Broglia C, Carnevale Maffè G, Ruga A, Molinari E, Ascari E. Gobbi PG, et al. Haematologica. 2002 Nov;87(11):1151-6. Haematologica. 2002. PMID: 12414344

2

The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas.

Gobbi PG, Ghirardelli ML, Cavalli C, Baldini L, Broglia C, Clò V, Bertè R, Ilariucci F, Carotenuto M, Piccinini L, Stelitano C, Attardo-Parrinello G, Ascari E. Gobbi PG, et al. Haematologica. 2000 Apr;85(4):372-80. Haematologica. 2000. PMID: 10756362

3

Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD).

Gobbi PG, Comelli M, Grignani GE, Pieresca C, Bertoloni D, Ascari E. Gobbi PG, et al. Haematologica. 1994 May-Jun;79(3):241-55. Haematologica. 1994. PMID: 7926973

4

Primary splenic lymphoma: does it exist?

Gobbi PG, Grignani GE, Pozzetti U, Bertoloni D, Pieresca C, Montagna G, Ascari E. Gobbi PG, et al. Haematologica. 1994 May-Jun;79(3):286-93. Haematologica. 1994. PMID: 7926983 Review.

5

A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).

Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E. Gobbi PG, et al. Haematologica. 2000 Mar;85(3):263-8. Haematologica. 2000. PMID: 10702814

6

Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.

Gobbi PG, Broglia C, Bertè R, Petrilli MP, Molica S, Angrilli F, Iannitto E, Ghirardelli ML, Di Renzo N, Cavanna L, Ascari E. Gobbi PG, et al. Haematologica. 2000 Jul;85(7):722-8. Haematologica. 2000. PMID: 10897124 Clinical Trial.

7

Prognostic factors in malignant lymphomas (Hodgkin and non-Hodgkin).

Ascari E, Gobbi PG. Ascari E, et al. Among authors: gobbi pg. Acta Haematol. 1987;78 Suppl 1:146-50. doi: 10.1159/000205921. Acta Haematol. 1987. PMID: 3124438

8

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.

Gobbi PG, Broglia C, Merli F, Dell'Olio M, Stelitano C, Iannitto E, Federico M, Bertè R, Luisi D, Molica S, Cavalli C, Dezza L, Ascari E. Gobbi PG, et al. Cancer. 2003 Dec 1;98(11):2393-401. doi: 10.1002/cncr.11807. Cancer. 2003. PMID: 14635074 Free article.

9

The clinical value of tumor burden at diagnosis in Hodgkin lymphoma.

Gobbi PG, Broglia C, Di Giulio G, Mantelli M, Anselmo P, Merli F, Zinzani PL, Rossi G, Callea V, Iannitto E, Paulli M, Garioni L, Ascari E. Gobbi PG, et al. Cancer. 2004 Oct 15;101(8):1824-34. doi: 10.1002/cncr.20568. Cancer. 2004. PMID: 15372482 Free article.

10

MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.

Riccardi A, Gobbi P, Danova M, Giordano M, Pieresca C, Bertoloni D, Brugnatelli S, Ascari E. Riccardi A, et al. Haematologica. 1993 Jan-Feb;78(1):44-8. Haematologica. 1993. PMID: 7684012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters